| Mrs Cynthia Napier, CRNA | |
|
One Saint Joseph Drive, Lexington, KY 40504 | |
| (859) 313-1000 | |
| Not Available |
| Full Name | Mrs Cynthia Napier |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | One Saint Joseph Drive, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023454907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN766723 (Pennsylvania) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 92533 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Georgetown Community Hospital | Georgetown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Anesthesia Group Psc | 4082527890 | 37 |
| Central Kentucky Anesthesia P.s.c. | 4880508712 | 49 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Entity Name | Kentucky Anesthesia Group Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073608634 PECOS PAC ID: 4082527890 Enrollment ID: O20031107000511 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Entity Name | Central Kentucky Anesthesia P.s.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518083161 PECOS PAC ID: 4880508712 Enrollment ID: O20031115000040 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Entity Name | Ephraim Mcdowell Health Resource Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487708533 PECOS PAC ID: 7517876956 Enrollment ID: O20031218000776 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Entity Name | Anesthesia Associates, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902991169 PECOS PAC ID: 3678569068 Enrollment ID: O20040421001618 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Entity Name | Anesthesia Health Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336528926 PECOS PAC ID: 4688977218 Enrollment ID: O20160114001985 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cynthia Napier, CRNA 1 Saint Joseph Dr, Lexington, KY 40504-3742 Ph: (859) 313-1000 | Mrs Cynthia Napier, CRNA One Saint Joseph Drive, Lexington, KY 40504 Ph: (859) 313-1000 |
News Archive
In the latest in the bird flu furore it now appears that the dealer in exotic birds at the centre of Britain's first bird flu outbreak is a convicted VAT fraudster.
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 4 days ago
Keesha Ovee Watts, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
Robert Jason Crafton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Department Of Anesthesiology, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-218-1080 | |
Kathleen Whitehouse, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-967-5000 | |
Richi C Gambrel, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 Rose Street, Lexington, KY 40536 Phone: 859-323-5000 | |
Mr. John Stepan Pototsky, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
Ms. Cathleen D. Bentley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-967-5000 |